Gujarat plant of Sun Pharma hit by import ban from FDA

Pharma Admission

pharma admission

 

Karkhadi (Gujarat) based plant of Sun Pharmaceuticals imposed ban by USFDA. This ban is applied on import of all drug products from this plant. This detention was carried out without physical examination of drugs because company failed to met good manufacturing practices rules, as per FDA website on Wednesday.

Sun Pharma is leading pharmaceutical company from India and the biggest drug maker by value. And this import alert resulted in fall of shares of company on Thursday.

This is well known that in the US around 40% of drugs are imported from India and India is second placed for import of generics after Canada.

This ban on Sun Pharm may affect import business from indigenous pharmaceuticals as FDA had also recently banned Ranbaxy and Wockhardt.


Latest News